Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Azole derivative

A technology of azole derivatives and alkyl groups, applied in the field of azole derivatives, can solve the problems such as no reports of compounds with azole skeletons

Active Publication Date: 2014-06-25
TAISHO PHARMACEUTICAL CO LTD
View PDF19 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report on the compounds with azole skeletons disclosed in the present invention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Azole derivative
  • Azole derivative
  • Azole derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment A－01

[1400] ·Example A-01: 2-[2-(3-chlorophenyl)-4-{4-[2-(piperidin-1-yl)ethyl]phenyl}-1H-imidazol-1-yl Synthesis of ]-N-(propane-2-yl)acetamide

[1401] 【Chemical 226】

[1402]

[1403] CHCl of the compound (533 mg) obtained in Reference Example P-A04 3 (11mL) solution, add Et 3 N (0.28 mL), MsCl (0.12 mL) was added under ice-cold conditions, and stirred at room temperature for 2.5 hours. Under ice-cold conditions, after adding water, use CHCl 3 Extract and concentrate the filtrate under reduced pressure. The obtained residue was subjected to OH silica gel column chromatography (mobile phase: CHCl 3 / EtOAc=70 / 30; v / v) to obtain methanesulfonyl compound (414mg, colorless solid).

[1404] The obtained methanesulfonyl compound (102mg), piperidine (0.042mL), iPr 2 A mixture of NEt (0.073 mL) and MeCN (2.0 mL) was reacted by microwave (100°C, 1.5 hours). Reversed-phase column chromatography (mobile phase: 0.1% TFA MeCN / H 2 O=10 / 90~90 / 10; v / v) refined. Wash the fractions wi...

Embodiment A－02

[1408] ·Example A-02: 2-[2-(3-chlorophenyl)-4-{4-[2-(morpholin-4-yl)ethyl]phenyl}-1H-imidazol-1-yl ]-N-(propan-2-yl)acetamide

[1409] 【Chemical 227】

[1410]

[1411]

[1412]

[1413] .

Embodiment A－03

[1414] ·Example A-03: 2-[2-(3-Chlorophenyl)-4-{4-[2-(2-Oxa-6-azaspiro[3.3]heptane-6-yl)B Base]phenyl}-1H-imidazol-1-yl]-N-(propan-2-yl)acetamide

[1415] 【Chemical 228】

[1416]

[1417]

[1418] .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related disease, alopecia, and so forth. Specifically, the invention provides azole derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine-vasopressin (AVP) V1b receptor:

Description

technical field [0001] The present invention relates to an azole skeleton compound with antagonistic effect on the V1b receptor of arginine vasopressin (AVP) and a pharmaceutical composition using the compound as an active ingredient, in particular to emotional disorders (including depression), Anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, eating disorder, hypertension, digestive organ disease, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, headache Therapeutic or preventive agents for external trauma, inflammation, immune-related diseases, alopecia and other diseases. Background technique [0002] Arginine vasopressin (AVP) is a peptide composed of 9 amino acids, which is mainly biosynthesized in the hypothalamus. As a pituitary hormone, it is closely related to the regulation of plasma osmotic pressure, blood pressure and body fluid volume. [0003] Three subtypes of AVP receptors, V1a,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D207/444A61K31/4164A61K31/4178A61K31/4196A61K31/4439A61K31/444A61K31/454A61K31/4545A61K31/46A61K31/4725A61K31/496A61K31/537A61K31/5377A61K31/5386A61K31/541A61K31/553A61P1/04A61P9/10A61P9/12A61P17/14A61P25/00A61P25/08A61P25/14A61P25/16A61P25/18A61P25/22A61P25/28A61P25/30A61P29/00A61P37/02A61P43/00C07D231/12C07D233/64C07D233/70C07D249/08C07D249/10C07D263/32C07D277/20C07D277/30C07D401/04C07D401/10C07D403/04C07D403/06C07D403/10C07D413/10C07D451/06C07D491/107C07D498/08
CPCC07D249/08C07D451/06C07D403/04C07D249/12C07D498/08C07D403/10C07D233/64C07D277/30C07D231/12C07D401/04C07D233/90C07D491/107C07D233/70C07D471/08C07D277/20C07D401/10C07D413/10C07D207/444C07D403/06C07D249/10C07D263/32A61P1/00A61P1/04A61P17/00A61P17/14A61P25/00A61P25/08A61P25/14A61P25/16A61P25/18A61P25/22A61P25/24A61P25/28A61P25/30A61P29/00A61P37/02A61P43/00A61P9/00A61P9/10A61P9/12A61K31/4164A61K31/4178A61K31/4196A61K31/4439A61K31/444A61K31/454A61K31/4545A61K31/46A61K31/4725A61K31/496A61K31/537A61K31/5377A61K31/5386A61K31/541A61K31/553
Inventor 吉永光周桑田刚志宫腰直树石坂知子若杉大介城川伸一服部信隆岛崎洋一
Owner TAISHO PHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com